Dosis

Nama Obat 8/8/2022 8/9/2022 ### 8/11/2022 ### ###

P
Meropenem 3 x 320 v v v v v v
Midazolam 24 mg ~ 50cc v v v v v v
PCT 10 mg/kgBB v v v v v v

Inhalasi Ventolin 1 resp v v v v v v

KAEN 3B 800 cc/hr 33,3 cc/j 33,3 cc/j ↓20 cc/j ↓13,33 cc/j 13,3 cc/j 13,3 cc/j

Lasix 0,5 mg / kgBB v v v v v

Amikasin 1 x 145 mg v
Ceftazidime 3 x 400 mg

Inhalasi Pulmicort 1 resp

Dosis
Nama Obat 8/8/2022 8/9/2022 ### 8/11/2022 ### ###
Non
Zinc 1 x 20 mg v v v
Vitamin A 1x1 v v S
Lacto B 1x1 v v v

Puyer Vitamin
(Asam Folat, 1x1 v v v
Vitamin B1, B6,
B12)
Zinc Oxide 2x1 v v v v v
Nystatin 3 x 1 cc v v v v v
Salbutamol 3 x 0,5 cc
 Waktu Penggunaan
Dosis
Nama Obat ### ### ### 8/20/2022 ### ###
Parenteral
24 mg ~ 50cc
Myloz (08 STOP

10 mg/kgBB
PCT
(08 /6J /6J /6J /6J /6J /6J
KAEN 3B 1 cc/jam 1 cc/jam 1 cc/jam 1 cc/jam 1 cc/jam 0,5 cc/jam 0,5 cc/jam
Lasix 2x4g 06.12 06.12 06.12 06.12 06.12 06.12
Amikasin 1 x 145 mg 15 (10/10)15 (10/10)15 (10/10) 15 (10/10) 12 12
Ceftazidime 3 x 400 mg 06.12.18
(15/ STOP
11 (10/10)11 (10/10)11 (10/10) 11 (10/10)
Inhalasi Ventolin 1 resp (15- /3J /3J /3J /3J /3J /3J

Waktu Penggunaan
Dosis
Nama Obat ### ### ### 8/20/2022 ### ###
Non Parenteral
Zinc 1 x 20 mg (09 18 18 18 18 18 18
Lacto B 1 x 1 (11- 18 18 18 18 18 18
Puyer Vitamin 1 x 1 (11- 18 18 18 18 18 18
Zinc Oxide 2 x 1 (12- 09.18 09.18 09.18 09.18 09.18.22 09.18.22
Nystatin 3 x 1 cc (14- 09.18.22 09.18.22 09.18.22 09.18.22 06.12.18 06.12.18
Salbutamol 3 x 0,5 mg
Tanggal 8/15/2022 ### ### ### 8/23/2022 ### ###
GCS Somnolent SomnolentSomnolentC. Mentis C. Mentis C. Mentis C. Mentis
 Waktu Penggunaan
### ### ### ### ### ### ### 8/21/2022 ###
Parenteral
v S
v v v S
v v v v v v v v v

v v v S v v

13,3 cc/j 13,3 cc/j ↓1 cc/j 1 cc/j 1 cc/j 1 cc/j 1 cc/j ↓0,5 cc/j 0.5 cc/j

v ↑2x4 mg v v v v v v S

v v v v v v v v v
v v v v v v v S

v v v S

Waktu Penggunaan
### ### ### ### ### ### ### 8/21/2022 ###
Non Parenteral
v v v v v v v

v v v v v v v v v

v v v v v v v v v

v v v v v v v v S
v v v v v v v v v
aan
### ### ###

/6J /6J /6J

0,5 cc/jam 0,5 cc/jam 0,5 cc/jam
06.12 06.12 06.12
12 12 12

/3J /3J /3J

aan
### ### ###

18 18 18
18 STOP
18 18 18
09.18.22 09.18.22 09.18.22
06.12.18 06.12.18 06.12.18
06.12.18 06.12.18 06.12.18
 ### ### ###

v v v

0.5 cc/j 0.5 cc/j 0.5 cc/j

v v v

### ### ###

S
v

v v v

v v v
v v S
No

3
4

No
1
2
3

5
Ho, K. M., & Power, B. M. (2010). Benefits and risks of furosemide in acute kidney injury
NIEDERMAN, Michael S., et al. 2020, Inhaled amikacin adjunctive to intravenous standard-of-c
Cousson, J., Floch, T., Guillard, T., Vernet, V., Raclot, P., Wolak-Thierry, A., & Jolly, D. (2015).
Giglio, Mariateresa, et al. 2012, "Oral nystatin prophylaxis in surgical/trauma ICU patients: a ran

Nama Obat Tepat Indikasi Tepat Dosis Sumber

Pneumonia,
Meropenem SMRS Curiga (v) < 1 g / hari Medscape
Sepsis

(v) 50-100
Midazolam Sedatif mcg/kg IV over Medscape
2-3 min

PCT Antipiretik (x) 15 mg/kgBB Medscape

Furosemide Diuretik (AKI) (v) 0.1 - 1 mg/kg Ho and
Power, 2010

Terapi Medscape
(v) 15-22.5
Amikasin tambahan mg/kg/hari Niederman,
Pneumonia et al. 2020

Pneumonia, Medscape
(v) 30-5-
Ceftazidime SMRS Curiga mg/kg/8j Cousson, et
Sepsis al. 2015

Nama Obat Tepat Indikasi Tepat Dosis Sumber

Zinc Elektrolit (v) 20 mg/hr Medscape
Lacto B Probiotik (v) 1 x 1 sach
Zinc Oxide Diaper Rash (v) 2 x 1

Nystatin Profilaksis (v) 3 x 1 cc Giglio, et al.

Candida 2012

Salbutamol (v) < 12mg/ hari

SABA Medscape
cute kidney injury. Anaesthesia, 65(3), 283-293.
nous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INH
& Jolly, D. (2015). Lung concentrations of ceftazidime administered by continuous versus intermittent infu
ICU patients: a randomised clinical trial." Critical Care 16.2: 1-9.
negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.
us versus intermittent infusion in patients with ventilator-associated pneumonia. Antimicrobial Agents and
 phase 3, superiority trial. The Lancet Infectious Diseases, 20.3: 330-340.
 Antimicrobial Agents and Chemotherapy, 59(4), 1905-1909.